• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

地高辛经肾小管细胞单层(LLC-PK1)的能量依赖性转运。

Energy-dependent transport of digoxin across renal tubular cell monolayers (LLC-PK1).

作者信息

Ito S, Koren G, Harper P A, Silverman M

机构信息

Department of Paediatrics and Pharmacology, Research Institute, Hospital for Sick Children, Toronto, Ont., Canada.

出版信息

Can J Physiol Pharmacol. 1993 Jan;71(1):40-7. doi: 10.1139/y93-006.

DOI:10.1139/y93-006
PMID:8099844
Abstract

Digoxin secretory transport across renal tubular cell monolayers (LLC-PK1) grown on permeable filters was characterized. Metabolic inhibitors reduced total and specific basolateral to apical (B-A) flux of digoxin and conversely increased the apical to basolateral (A-B) flux. The specific transport of digoxin from the basolateral to the apical compartment was saturable, with a maximum velocity of transport of 184.5 +/- 38.0 pmol.cm-2.h-1 and a Michaelis-Menten constant (Km) of 14.1 +/- 1.6 microM. In addition, B-A flux of digoxin resulted in accumulation of digoxin in the apical compartment against the concentration gradient. P-Glycoprotein inhibitors such as quinidine, verapamil, vincristine, and cyclosporine increased the net A-B flux and inhibited the total B-A flux without affecting the nonspecific flux significantly. Tetraethylammonium, a prototype substrate for an organic cation transport system, had no such effect. Our results suggest that digoxin undergoes transepithelial secretion by an energy-dependent, carrier-mediated process in renal tubules, a process that seems to be distinct from the tetraethylammonium transport system.

摘要

对生长在可渗透滤膜上的肾小管细胞单层(LLC-PK1)中地高辛的分泌转运进行了表征。代谢抑制剂降低了地高辛从基底外侧到顶端(B-A)的总通量和特异性通量,反之增加了从顶端到基底外侧(A-B)的通量。地高辛从基底外侧到顶端隔室的特异性转运是可饱和的,最大转运速度为184.5±38.0 pmol·cm⁻²·h⁻¹,米氏常数(Km)为14.1±1.6 μM。此外,地高辛的B-A通量导致地高辛在顶端隔室中逆浓度梯度积累。奎尼丁、维拉帕米、长春新碱和环孢素等P-糖蛋白抑制剂增加了净A-B通量并抑制了总B-A通量,而对非特异性通量没有显著影响。有机阳离子转运系统的原型底物四乙铵没有这种作用。我们的结果表明,地高辛在肾小管中通过能量依赖的、载体介导的过程进行跨上皮分泌,这一过程似乎与四乙铵转运系统不同。

相似文献

1
Energy-dependent transport of digoxin across renal tubular cell monolayers (LLC-PK1).地高辛经肾小管细胞单层(LLC-PK1)的能量依赖性转运。
Can J Physiol Pharmacol. 1993 Jan;71(1):40-7. doi: 10.1139/y93-006.
2
P-glycoprotein-mediated renal tubular secretion of digoxin: the toxicological significance of the urine-blood barrier model.
Life Sci. 1993;53(2):PL25-31. doi: 10.1016/0024-3205(93)90667-r.
3
Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1).地高辛在猪肾上皮细胞系(LLC-PK1)中表达的人P-糖蛋白介导下的转运。
J Pharmacol Exp Ther. 1992 Nov;263(2):840-5.
4
Directional transcellular transport of bisoprolol in P-glycoprotein-expressed LLC-GA5-COL150 cells, but not in renal epithelial LLC-PK1 Cells.比索洛尔在表达P-糖蛋白的LLC-GA5-COL150细胞中存在定向跨细胞转运,但在肾上皮LLC-PK1细胞中不存在。
Drug Metab Pharmacokinet. 2008;23(5):340-6. doi: 10.2133/dmpk.23.340.
5
Mediation of cimetidine secretion by P-glycoprotein and a novel H(+)-coupled mechanism in cultured renal epithelial monolayers of LLC-PK1 cells.在LLC-PK1细胞的培养肾上皮单层中,P-糖蛋白和一种新型H⁺偶联机制对西咪替丁分泌的介导作用。
Br J Pharmacol. 1996 Mar;117(6):1139-44. doi: 10.1111/j.1476-5381.1996.tb16708.x.
6
Handling of digoxin and ouabain by renal tubular cells (LLC-PK1).
J Pharmacol Exp Ther. 1992 Jul;262(1):109-13.
7
The mechanism of the verapamil-digoxin interaction in renal tubular cells (LLC-PK1).维拉帕米与地高辛在肾小管细胞(LLC-PK1)中的相互作用机制。
Life Sci. 1993;53(24):PL399-403. doi: 10.1016/0024-3205(93)90495-o.
8
Distinct characteristics of transcellular transport between nicotine and tetraethylammonium in LLC-PK1 cells.LLC-PK1细胞中尼古丁和四乙铵跨细胞转运的不同特征。
J Pharmacol Exp Ther. 1998 Aug;286(2):676-80.
9
Transepithelial transport of drugs by the multidrug transporter in cultured Madin-Darby canine kidney cell epithelia.多药转运体在培养的Madin-Darby犬肾细胞上皮中对药物的跨上皮转运
J Biol Chem. 1989 Sep 5;264(25):14880-4.
10
Transport and epithelial secretion of the cardiac glycoside, digoxin, by human intestinal epithelial (Caco-2) cells.人肠上皮(Caco-2)细胞对强心苷地高辛的转运及上皮分泌
Br J Pharmacol. 1996 Jul;118(6):1389-96. doi: 10.1111/j.1476-5381.1996.tb15550.x.

引用本文的文献

1
The influence of bariatric surgery on oral drug bioavailability in patients with obesity: A systematic review.肥胖患者减重手术对口服药物生物利用度的影响:系统评价。
Obes Rev. 2019 Sep;20(9):1299-1311. doi: 10.1111/obr.12869. Epub 2019 Jun 24.
2
Central nervous system (CNS) delivery of glucocorticoids is fine-tuned by saturable transporters at the blood-CNS barriers and nonbarrier regions.糖皮质激素经中枢神经系统(CNS)给药,由血脑屏障和非屏障区域的可饱和转运体进行精细调控。
Endocrinology. 2010 Nov;151(11):5294-305. doi: 10.1210/en.2010-0554. Epub 2010 Sep 29.
3
Evaluation of in vivo P-glycoprotein phenotyping probes: a need for validation.
体内 P-糖蛋白表型探针的评价:验证的必要性。
Clin Pharmacokinet. 2010 Apr;49(4):223-37. doi: 10.2165/11318000-000000000-00000.
4
Identifying candidate causal variants responsible for altered activity of the ABCB1 multidrug resistance gene.鉴定导致ABCB1多药耐药基因活性改变的候选因果变异体。
Genome Res. 2004 Jul;14(7):1333-44. doi: 10.1101/gr.1965304. Epub 2004 Jun 14.
5
The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin.肠道P-糖蛋白在地高辛与利福平相互作用中的作用。
J Clin Invest. 1999 Jul;104(2):147-53. doi: 10.1172/JCI6663.
6
Drug exsorption from blood into the gastrointestinal tract.药物从血液中解吸附进入胃肠道。
Pharm Res. 1998 Mar;15(3):371-6. doi: 10.1023/a:1011959828103.
7
Relevance of p-glycoprotein for the enteral absorption of cyclosporin A: in vitro-in vivo correlation.P-糖蛋白对环孢素A肠吸收的相关性:体外-体内相关性
Br J Pharmacol. 1996 Aug;118(7):1841-7. doi: 10.1111/j.1476-5381.1996.tb15612.x.
8
Transport and epithelial secretion of the cardiac glycoside, digoxin, by human intestinal epithelial (Caco-2) cells.人肠上皮(Caco-2)细胞对强心苷地高辛的转运及上皮分泌
Br J Pharmacol. 1996 Jul;118(6):1389-96. doi: 10.1111/j.1476-5381.1996.tb15550.x.